NeuroMetrix Announces Quell Dispensing Partnership with Comprehensive Pain Specialists

WALTHAM, Mass.--(BUSINESS WIRE)--

NeuroMetrix, Inc. NURO announced today that Comprehensive Pain Specialists will offer Quell® Wearable Pain Relief Technology™ in selected clinic locations.

"We are pleased that a growing number of forward-thinking pain management providers are integrating the Quell technology into their treatment protocols," said Shai N.Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. "We know that patients look to their healthcare providers for information on the newest pain relief options and value recommendations at the point-of-service from our provider partners."

"We are always looking for innovative pain relief technologies to offer patients as part of an individualized treatment plan," said Peter Kroll, M.D., Medical Director of Comprehensive Pain Specialists. "We are excited to offer Quell technology to our patients as part of a multidisciplinary approach to pain management."

About Comprehensive Pain Specialists

Comprehensive Pain Specialists, formed in 2005, is a group of experienced physicians and staff dedicated to identifying and treating chronic pain. With 60+ locations in 12 states across the country, CPS combines evolving, precision diagnostics and innovative therapies to assist each patient with their chronic pain management needs. For more information, please visit www.cpspain.com.

About Quell

Quell is designed for millions of people suffering from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell users can start, stop, and adjust therapy discreetly via the optional Quell Relief app. Quell also offers advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night. Quell was the winner of the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. Quell is available at select healthcare professionals and retailers. To find a Quell retailer near you, visit the Store Locator at QuellRelief.com.

About NeuroMetrix

NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform that helps patients optimize their therapy and decrease the impact of chronic pain on their quality of life. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has several pipeline programs, including a therapeutic device for restless leg syndrome. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!